How many studies have been conducted on Eosinophil Cationic Protein?

BiohacksAI has indexed 300 PubMed studies on Eosinophil Cationic Protein, including 4 randomized controlled trials (RCTs). 57% of studies involve human subjects.

What are the main research areas for Eosinophil Cationic Protein?

The primary research domains for Eosinophil Cationic Protein are 🫁 Respiratory, 🔬 Inflammation, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Eosinophil Cationic Protein

One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil cationic protein is a 21-kDa cytotoxic peptide with a pI of 10.9. Although eosinophil cationic protein is considered a member of the RNAse A superfamily of proteins, it has only limited RNAse activity.

300+ PubMed studies analyzed · 4 RCTs · Evidence Score: 47.6

Research Domains

Eosinophil Cationic Protein has been studied across 17 research domains including 🫁 Respiratory, 🔬 Inflammation, 🔬 Oncology, ✨ Skin & Hair, 😴 Sleep. The primary research focus is 🫁 Respiratory with 29% of studies addressing this area.

Loading evidence profile...

This evidence profile for Eosinophil Cationic Protein is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.